Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Net Income: 2011-2025

Historic Net Income for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -$35.6 million.

  • Abeona Therapeutics' Net Income fell 17.47% to -$35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.1 million, marking a year-over-year increase of 4.84%. This contributed to the annual value of -$68.4 million for FY2024, which is 43.88% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Net Income is -$35.6 million, which was down 195.60% from -$12.0 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Net Income ranged from a high of -$8.2 million in Q2 2022 and a low of -$46.7 million during Q4 2021.
  • In the last 3 years, Abeona Therapeutics' Net Income had a median value of -$15.3 million in 2024 and averaged -$19.2 million.
  • As far as peak fluctuations go, Abeona Therapeutics' Net Income spiked by 71.90% in 2022, and later crashed by 196.31% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Net Income (Quarterly) stood at -$46.7 million in 2021, then skyrocketed by 71.90% to -$13.1 million in 2022, then dropped by 1.56% to -$13.3 million in 2023, then plummeted by 33.31% to -$17.8 million in 2024, then dropped by 17.47% to -$35.6 million in 2025.
  • Its Net Income was -$35.6 million in Q3 2025, compared to -$12.0 million in Q2 2025 and -$20.7 million in Q1 2025.